Alimera Sciences' CEO Dan Myers to Present During Ophthalmology Innovation Summit at American Academy of Ophthalmology 2017

ATLANTA, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that Dan Myers, Chief Executive Officer of Alimera, will present at the Ophthalmology Innovation Summit (OIS) to be held Thursday, November 9, 2017 in conjunction with the 2017 American Academy of Ophthalmology (AAO) in New Orleans. Mr. Myers will be speaking as part of the Public Device and BioPharma Company Showcase scheduled for 3:35-4:45 p.m.